CN Patent

CN102341091A — 利鲁唑水性悬浮液

Assigned to Italfarmaco SpA · Expires 2012-02-01 · 14y expired

What this patent protects

本发明涉及理化性质稳定的利鲁唑水性悬浮液及其制备方法。该水性悬浮液包含颗粒形式的利鲁唑，和至少一种润湿剂，优选表面活性剂形式。利鲁唑的用量在约0.1％至约20％w/v之间且平均粒径小于200μm；该悬浮液完全避免了利鲁唑已知的局部(嘴部)麻醉作用。

USPTO Abstract

本发明涉及理化性质稳定的利鲁唑水性悬浮液及其制备方法。该水性悬浮液包含颗粒形式的利鲁唑，和至少一种润湿剂，优选表面活性剂形式。利鲁唑的用量在约0.1％至约20％w/v之间且平均粒径小于200μm；该悬浮液完全避免了利鲁唑已知的局部(嘴部)麻醉作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN102341091A
Jurisdiction
CN
Classification
—
Expires
2012-02-01
Drug substance claim
No
Drug product claim
No
Assignee
Italfarmaco SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.